Kennedy Capital Management’s Edgewise Therapeutics EWTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.31M | Buy |
252,524
+27,824
| +12% | +$365K | 0.08% | 356 |
|
|
2025
Q1 | $4.94M | Sell |
224,700
-11,942
| -5% | -$263K | 0.12% | 288 |
|
|
2024
Q4 | $6.32M | Buy |
236,642
+9,619
| +4% | +$257K | 0.14% | 262 |
|
|
2024
Q3 | $6.06M | Sell |
227,023
-45,048
| -17% | -$1.2M | 0.13% | 265 |
|
|
2024
Q2 | $4.9M | Sell |
272,071
-21,194
| -7% | -$382K | 0.1% | 322 |
|
|
2024
Q1 | $5.35M | Sell |
293,265
-49,599
| -14% | -$905K | 0.11% | 308 |
|
|
2023
Q4 | $3.75M | Buy |
+342,864
| New | +$3.75M | 0.08% | 361 |
|